2008
DOI: 10.1021/bi801249c
|View full text |Cite
|
Sign up to set email alerts
|

ABCA1 Promotes the de Novo Biogenesis of Apolipoprotein CIII-Containing HDL Particles in Vivo and Modulates the Severity of Apolipoprotein CIII-Induced Hypertriglyceridemia

Abstract: In this study, the ability of the lipid transporter ABCA1 and apolipoprotein CIII (apoCIII) to promote the de novo biogenesis of apoCIII-containing HDL in vivo and the role of this HDL in apoCIII-induced hypertriglyceridemia were investigated, using adenovirus-mediated gene transfer in apoE (-/-) x apoA-I (-/-) mice or ABCA1 (-/-) mice. Injection of apoE (-/-) x apoA-I (-/-) mice with 8 x 10 (8) pfu of an adenovirus expressing the wild-type human apoCIII (AdGFP-CIII g) generated HDL-like particles and triggere… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
53
0
3

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 53 publications
(61 citation statements)
references
References 58 publications
3
53
0
3
Order By: Relevance
“…For example, Wang et al (10) showed that VLDL from TD subjects was enriched with apoA-II and apoC-III, compared with VLDL from normolipidemic subjects, resulting in a reduced lipase accessibility. Consistent with this notion, Kyreos et al (41) recently showed that adenoviral overexpression of human apoC-III in apoE KO and ABCA1 KO mice induces hypertriglyceridemia due to low LPL reactivity of apoC-III-enriched VLDL. In addition to possible effects on VLDL substrate, our mouse model also showed that both HL and LPL were markedly reduced upon deletion of hepatic ABCA1 (Fig.…”
Section: Discussionmentioning
confidence: 69%
“…For example, Wang et al (10) showed that VLDL from TD subjects was enriched with apoA-II and apoC-III, compared with VLDL from normolipidemic subjects, resulting in a reduced lipase accessibility. Consistent with this notion, Kyreos et al (41) recently showed that adenoviral overexpression of human apoC-III in apoE KO and ABCA1 KO mice induces hypertriglyceridemia due to low LPL reactivity of apoC-III-enriched VLDL. In addition to possible effects on VLDL substrate, our mouse model also showed that both HL and LPL were markedly reduced upon deletion of hepatic ABCA1 (Fig.…”
Section: Discussionmentioning
confidence: 69%
“…The mutagenic primers used were: 5′-TTGGC CGCGC GCCTT GAG-3′ (forward) and 5′-CTGGC GCAGC TCGTC GCT-3′ (reverse) with the pCA13-AIgN vector (23), which contains the genomic human apoA-I sequence, as template. The recombinant adenoviruses were constructed as described previously (24). The titer of the virus preparation was 2 × 10 10 pfu/mL.…”
Section: Generation and Large-scale Production Of The Recombinant Attmentioning
confidence: 99%
“…Western blot analysis for apoA-I was performed as described previously (24), using a goat anti-human apoA-I antibody (cat# K45252G; Biodesign International, Saco, ME, USA) as primary, and a rabbit anti-goat antibody (cat # sc-2768; Santa-Cruz Biotechnology, Sant Cruz, CA, USA) as secondary. For analysis of culture medium, 100 μL of medium was extensively dialyzed in H 2 0 and then lyophilized.…”
Section: Western Blot Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…Apolipoprotein C-III is mainly involved in modulating plasma triglyceride levels by the catabolism of triglyceride-rich particles, but plasma apolipoprotein C-III levels have been suggested to be linked to other conditions associated with metabolic syndrome (29). Apolipoprotein C-III-containing HDL may play a key role in the prevention of apolipoprotein C-III-induced hypertriglyceridemia (30). Recently, SELDI-TOF (surface-enhanced laser desorption ionization time of flight) analysis suggests a link between an ion species at m∕z 8,697 of apolipoprotein C-III and papillary thyroid carcinoma (31).…”
Section: Resultsmentioning
confidence: 99%